2025 Q4 -tulosraportti
36 päivää sitten
‧32 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 605 | - | - | ||
| 11 679 | - | - | ||
| 17 284 | - | - | ||
| 30 | - | - | ||
| 18 171 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·1 t sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend
·48 min sittenHehe. What is wrong with what I'm writing?? In Brain+ there was also a self-proclaimed expert who wrote 5-6 unilaterally positive posts daily throughout the company's lifetime. He got many likes for that. He also liked to count the number of Nordnetters and attached great importance to it. Despite his popularity and an increasing number of Nordnetters, Brain+ actually fell every single day from when they listed on the stock exchange until they went bankrupt a few weeks ago. So no, the number of Nordnetters means absolutely nothing. So you have wasted people's time with irrelevant numbers and a flawed conclusion- ·2 t sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·9 t sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
·1 päivä sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenI can only say that more and more shareholders have set their sights on Bioporto. I guess that there will be 8000 plus, within a short time, just like in the good old days.·7 t sitten3D Sometimes you just don't need to say anything :-)- ·1 päivä sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
36 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 t sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend·48 min sittenHehe. What is wrong with what I'm writing?? In Brain+ there was also a self-proclaimed expert who wrote 5-6 unilaterally positive posts daily throughout the company's lifetime. He got many likes for that. He also liked to count the number of Nordnetters and attached great importance to it. Despite his popularity and an increasing number of Nordnetters, Brain+ actually fell every single day from when they listed on the stock exchange until they went bankrupt a few weeks ago. So no, the number of Nordnetters means absolutely nothing. So you have wasted people's time with irrelevant numbers and a flawed conclusion
- ·2 t sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·9 t sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
- ·1 päivä sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenI can only say that more and more shareholders have set their sights on Bioporto. I guess that there will be 8000 plus, within a short time, just like in the good old days.·7 t sitten3D Sometimes you just don't need to say anything :-)
- ·1 päivä sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 605 | - | - | ||
| 11 679 | - | - | ||
| 17 284 | - | - | ||
| 30 | - | - | ||
| 18 171 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
2025 Q4 -tulosraportti
36 päivää sitten
‧32 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 21.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 | ||
2024 Q4 -tulosraportti 20.3.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·1 t sittenIn one year, the number of shareholders (here "Owners at Nordnet") has fallen by 740 to 7344. It is a well-known phenomenon that smaller (private) investors often sell under pressure, while larger (institutional) investors utilize the drop to accumulate shares cheaply. This largely applies also to sectors like biotech and healthcare. Here are the most important mechanisms behind this dynamic: 1. The psychology behind the fall (Small vs. Big) The small investors (Retail): Many private investors are driven by emotions like fear and "loss aversion". When a speculative stock falls for a whole year, they lose patience or panic over the red figures and often sell near the bottom to "save what can be saved". The large investors (Institutional): Professional asset managers and funds often look at fundamental values. They can afford to wait and often use long price drops to "absorb" shares in what is called the accumulation phase. "Tourist" investors: During boom times, private "tourist investors" flock to biotech for quick gains, but they flee in adversity, which creates the sharp dips that the larger/professional investors exploit. It is a classic market cycle: The inexperienced sell in frustration at the bottom, after which the shares change hands to those with deep pockets and a longer time horizon. When the fundamental news (e.g., an FDA approval) finally hits, the large investors own a larger share of the company, and the small investors often end up buying back in at a much higher price. Good weekend·48 min sittenHehe. What is wrong with what I'm writing?? In Brain+ there was also a self-proclaimed expert who wrote 5-6 unilaterally positive posts daily throughout the company's lifetime. He got many likes for that. He also liked to count the number of Nordnetters and attached great importance to it. Despite his popularity and an increasing number of Nordnetters, Brain+ actually fell every single day from when they listed on the stock exchange until they went bankrupt a few weeks ago. So no, the number of Nordnetters means absolutely nothing. So you have wasted people's time with irrelevant numbers and a flawed conclusion
- ·2 t sittenNow for something pleasant just before we have the weekend. I just discovered that the 800,000 shareholder has adjusted their purchase offer upwards from 1.12 to 1.16, again below the selling price. Therefore, I believe it must be an inexperienced investor. Because if it's a professional, they have learned that it can become very expensive to come with a lowball offer.
- ·9 t sittenI have found out that specialists debated on Linkedin about the upcoming recommendation, So doctors from all over the world are ready to press the buy button, When/if a 1st degree recommendation comes. I still maintain that there will be a 1 / 2 solution. https://www.linkedin.com/posts/dr-rola-fayad_livelovemedicine-nephrology-kdigo-activity-7445016504254996480-uN7E/
- ·1 päivä sittenDear All I am now interested in Price Targets going forward.: How many have previously been on a·7 t sittenI can only say that more and more shareholders have set their sights on Bioporto. I guess that there will be 8000 plus, within a short time, just like in the good old days.·7 t sitten3D Sometimes you just don't need to say anything :-)
- ·1 päivä sittenI just discovered that Bioporto has created a new tab where they make sure to keep us updated and there they also inform how they view the matter. Their breaking news bar is the blue tab at the top of Bioporto's front page. I just skimmed through it, and everything I have written previously aligns with what they state on the page. If you scroll down you can sign up for a newsletter so you get notified when there is news from KDIGO. https://bioporto.com/kgido-announcement/
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 605 | - | - | ||
| 11 679 | - | - | ||
| 17 284 | - | - | ||
| 30 | - | - | ||
| 18 171 | - | - |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 1 773 106 | 1 773 106 | 0 | 0 |